Similar appetite would be Corevest, Lima One, or Temple View.  

What is your appetite for rehab? 

And you in the peanut gallery- I know, there are interest-only mortgages, but most investors don't use them.)So in summary, and apologies for the extremely long post, I just got rolling and couldn't help myself, real estate enhances the best in investors by inhibiting panic selling during kerfuffles of one sort or another, and suppresses the worst in us, which is our unwillingness to save money on a regular basis.

Shocked that there's an appetite for this stuff.

It is not the Dems engaging in voter suppression.  

I would recommend handing off the day to day to someone else4) depends on how you fund the first property5) USA... 6) My biggest concern is appetite to put more rent controls in place and/or tying rent to the unit, not to the tenant, but these concerns are provincially legislated (not federally).

The Special and Broad cover more types of losses and are typically a replacement cost basis rather than a depreciated settlement but make sure of that as that part can be endorsed on or off.With all of that being said markets are different and appetites from carriers are different around the country.  

This is ultimately where I wanted to be but my steps to get here were slow and methodical so I didn't take on too much risk and not understand the intricacies of the product that buyers are looking for.It really depends on your goals, what type of investment you want to get into and your appetite for risk.  

Generally, outside of seller financing, the types of debt available for MHPs are:Local & Regional Banks - You can find out which banks have an appetite for mobile home parks by asking the MH/RV brokers in your area, networking through other owners of parks in your area, or simply obtain list of the smaller banks in your area/region and call them to see if they have lent on parks in the past.

This is from a top UCSF doctor who has written books examining the problems with trials and studies:"Last 15 years an increase appetite for uncertainty at time of regulatory approval for drugs and drug products.